medigraphic.com
ISSN 1608-8921 (Impreso)

2022, Número 1

<< Anterior Siguiente >>

Gaceta Médica Espirituana 2022; 24 (1)


Genes humanos asociados a la infección por el SARS-CoV-2

Rodríguez DR, Rodríguez MY, Díaz AMT

Idioma: Español
Referencias bibliográficas: 41
Paginas: 102-119
Archivo PDF: 489.17 Kb.


RESUMEN

Fundamento: La variabilidad clínica de la infección por el SARS-CoV-2 se debe, en parte, a factores genéticos.
Objetivo: Describir los principales genes de susceptibilidad a la Covid-19.
Metodología: Se realizó una revisión bibliográfica en Google Académico, SciELO, Annual Reviews y PubMed Central. Los descriptores que se utilizaron para la búsqueda de los documentos fueron consultados en el DeCS, estos fueron: SARS-CoV-2, Covid-19, genética y predisposición genética a la enfermedad. Se seleccionaron artículos disponibles a texto completo en inglés y en español, preferentemente de revistas arbitradas por pares.
Resultados: Entre los genes implicados en la infección por el SARS-CoV-2 se encuentran DDX1 que promueve la replicación viral, IFITM1, IFITM2, IFITM3, IFNAR2 que codifican proteínas inducidas por el interferón, los genes de receptores (ACE2, ANPEP, DPP4), los genes de proteasas (TMPRSS2, furin, TMPRSS11D, CTSL, CTSB) que contribuyen a la entrada viral, genes de la respuesta inmune como ABO y metalopeptidasas como la familia ADAM. Se han detectado polimorfismos genéticos de riesgo.
Conclusiones: En la infección por el SARS-CoV-2 se produce una compleja interrelación entre factores ambientales y genéticos que determinan la susceptibilidad de las personas a la Covid y su gravedad. El papel de los genes en la susceptibilidad a la Covid-19 deberá continuar investigándose.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol [Internet]. 2020 [cited 2021 Nov 06];18(12):[approx.p.27. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751883/pdf/pbio.3001016.pdfç

  2. Dobrindt K, Hoagland DA, Seah C, Kassim B, O'Shea CP, Murphy A, et al. Common Genetic Variation in Humans Impacts In Vitro Susceptibility to SARS-CoV-2 Infection. Stem Cell Reports [Internet]. 2021 [cited 2021 Nov 06];16(3):505-518. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881728/pdf/main.pdf

  3. López-Farré A. Los genes de la susceptibilidad a la infección por Covid-19. An RANM [Internet]. 2020 [citado 17 Dic 2021];137(02):117-120. Disponible en: Disponible en: https://analesranm.es/wp-content/uploads/2020/numero_137_02/pdfs/rev04.pdf

  4. Morales Peralta E, Alvarez Fornaris MA. Covid-19: aspectos relacionados a la susceptibilidad genética y defectos congénitos. Rev haban cienc méd [Internet]. 2020 [citado 17 Dic 2021];19(5):[approx.12p.]. Disponible en: Disponible en: http://scielo.sld.cu/pdf/rhcm/v19n5/1729-519X-rhcm-19-05-e3595.pdf

  5. Daniloski Z, Jordan TX, Wessels HH, Hoagland DA, Kasela S, Legut M, et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells. Cell [Internet]. 2021 [cited 2021 Dec 17];184(1):92-105.e16. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584921/pdf/main.pdf

  6. Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020 [cited 17 Dec 2021];41(12):1100-1115. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556779/pdf/main.pdf

  7. Gill D, Arvanitis M, Carter P, Hernández Cordero AI, Jo B, et al. ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. R Soc Open Sci [Internet]. 2020 [cited 2021 Dec 17]:7(11). Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735342/pdf/rsos200958.pdf

  8. Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, et al. Common, low-frequency, rare, and ultra-rare coding variants contribute to Covid-19 severity. Hum Genet [Internet]. 2021 [cited 2021 Dec 17];141(1):147-173. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661833/pdf/439_2021_Article_2397.pdf

  9. Kasela S, Ortega VE, Martorella M, Garudadri S, Nguyen J, Ampleford E, et al. Genetic and non-genetic factors affecting the expression of Covid-19-relevant genes in the large airway epithelium. Genome Med [Internet]. 2021 [cited 2021 Nov 06];13(1):[approx.17p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059115/pdf/13073_2021_Article_866.pdf

  10. Kucher AN, Babushkina NP, Sleptcov AA, Nazarenko MS. Genetic Control of Human Infection with SARS-CoV-2. Russ J Genet [Internet]. 2021 [cited 2021 Dec 17];7(6):627-641. Available from: Available from: https://link.springer.com/article/10.1134/S1022795421050057

  11. Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene [Internet]. 2021 [cited 2021 Dec 06];808:145963. Available from: Available from: https://doi.org/10.1016/j.gene.2021.145963

  12. Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, et al. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther [Internet]. 2021 [cited 2021 Dec 17];6:233. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193598/pdf/41392_2021_Article_653.pdf

  13. Rodríguez Duque R, Miguel Soca PE. Farmacogenómica: principios y aplicaciones en la práctica médica. Rev haban cienc méd [Internet]. 2020 [citado 06 Nov 2021];19(6):e3128. Disponible en: Disponible en: http://scielo.sld.cu/pdf/rhcm/v19n6/1729-519X-rhcm-19-06-e3128.pdf

  14. Sánchez-Artigas R, Díaz-Armas M, Rodríguez-Duque R, Miguel-Soca P. Principios y aplicaciones médicas de la edición de genes mediante CRISPR/Cas. Medisur [Internet]. 2021 [citado 06 Nov 2021];19(6):[aprox. 9 p.]. Disponible en: Disponible en: http://www.medisur.sld.cu/index.php/medisur/article/view/5279/3643

  15. Gaziano L, Giambartolomei C, Pereira AC, Gaulton A, Posner DC, Swanson SA, et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for Covid-19. Nat Med [Internet]. 2021 [cited 2021 Dec 17];27(4):668-676. Available from: Available from: https://www.nature.com/articles/s41591-021-01310-z.pdf

  16. Pathak GA, Singh K, Miller-Fleming TW, Wendt FR, Ehsan N, Hou K, et al. Integrative genomic analyses identify susceptibility genes underlying Covid-19 hospitalization. Nat Commun [Internet]. 2021 [cited 2021 Dec 17];12(1):[approx. 11p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316582/pdf/41467_2021_Article_24824.pdf

  17. Liu D, Yang J, Feng B, Lue W, Zhao C, Li L. Mendelian randomization analysis identified genes pleiotropically associated with the risk and prognosis of Covid-19. J Infect [Internet]. 2021 [cited 2021 Nov 06];82(1):126-132. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698677/pdf/main.pdf

  18. Raskin S. Genetics of Covid-19. J Ped [Internet]. 2021 [cited 2021 Nov 06];97(4):378-386. Available from: Available from: https://jped.elsevier.es/en-pdf-S0021755720302114

  19. Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights. J Basic Microbiol [Internet]. 2021 [cited 2021 Dec 17];61(3):180-202. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013332/pdf/JOBM-61-180.pdf

  20. Desimmie BA, Raru YY, Awadh HM, He P, Teka S, Willenburg KS. Insights intoSARS-CoV-2 Persistence and Its Relevance. Viruses [Internet]. 2021 [cited 2021 Nov 6];13(6):[approx.22p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013332/pdf/JOBM-61-180.pdf

  21. Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell [Internet]. 2021 [cited 2021 Nov 06];184(15):3936-3948. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185186/pdf/main.pdf

  22. Expósito-Lara A, Feria-Díaz G, González-Benítez S, Miguel-Soca P. Variantes genéticas del SARS-CoV-2 y sus implicaciones clínicas. Medisan [Internet]. 2021 [citado 17 Dic 2021];25(6). Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185186/pdf/main.pdf

  23. Pacheco-Romero J. El enigma del coronavirus - Nueva variante ómicron - Nuevas inquietudes - La mujer. Rev peru ginecol obstet [Internet]. 2021 [citado 06 Dic 2021];67(4). Disponible en: Disponible en: http://51.222.106.123/index.php/RPGO/article/view/2380/2550

  24. Zhu C, He G, Yin Q, Zeng L, Ye X, Shi Y, et al. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge. J Med Virol [Internet]. 2021 [cited 2021 Dec 17];93(10):5729-5741. Available from: Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27132

  25. Díaz-Armas M, Sánchez-Artigas R, Matute-Respo T, Llumiquinga-Achi R. Proteína de la espícula del virus SARS-CoV-2 y su relación con la enzima convertidora de angiotensina-2. RIC [Internet]. 2021 [citado 06 Dic 2021];100(5). Disponible en: Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/3633/4918

  26. Yeung ML, Teng JLL, Jia L, Zhang C, Huang C, Cai J-P, et al. Soluble ACE2-mediated cell entry ofSARS-CoV-2 via interaction with proteinsrelated to the renin-angiotensin system. Cell [Internet]. 2021 [cited 2021 Dec 06];184(8):2212-2228. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923941/pdf/main.pdf

  27. Baranova A, Cao H, Zhang F. Unraveling Risk Genes of Covid-19 by Multi-Omics Integrative Analyses. Front Med (Lausanne) [Internet]. 2021 [cited 2021 Dec 17];8:[approx.8p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452849/pdf/fmed-08-738687.pdf

  28. Liu Y, Hu G, Wang Y, Ren W, Zhao X, Ji F, et al. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. Proc Natl Acad Sci U S A [Internet]. 2021 [cited 2021 Dec 17];118(12):[approx.9p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000431/pdf/pnas.202025373.pdf

  29. Secolin R, de Araujo TK, Gonsales MC, Rocha CS, Naslavsky M, Marco L, et al. Genetic variability in Covid-19-related genes in the Brazilian population. Hum Genome Var [Internet]. 2021 [cited 2021 Dec 17];8:[approx.9p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017521/pdf/41439_2021_Article_146.pdf

  30. Winstone H, Lista MJ, Reid AC, Bouton C, Pickering S, Galao RP, et al. The polybasiccleavage site in SARS-CoV-2 spike modulatesviral sensitivity to type I interferon and IFITM2. J Virol [Internet]. 2021 [cited 2021 Dec 06];95(9):e02422-20. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104117/pdf/JVI.02422-20.pdf

  31. Vanderheiden A, Ralfs P, Chirkova T, Upadhyay AA, Zimmerman MG, Bedoya S, et al. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol [Internet]. 2020 [cited 2021 Dec 17];94(19):e00985-20. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495371/pdf/JVI.00985-20.pdfç

  32. Carapito R, Li R, Helms J, Carapito C, Gujja S, Rolli V, et al. Identification of driver genes for critical forms of Covid-19 in a deeply phenotyped young patient cohort. Sci Transl Med. 2021 [cited 2021 Dec 06];10:1126. Available from: Available from: https://www.science.org/doi/pdf/10.1126/scitranslmed.abj7521

  33. Aljohmani A, Yildiz D. A Disintegrin and Metalloproteinase-Control Elements in Infectious Diseases. Front Cardiovasc Med [Internet]. 2020 [cited 2021 Dec 06];7: [approx.14p. ]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772189/pdf/fcvm-07-608281.pdf

  34. Covid-19 Host Genetics Initiative. Mapping the human genetic architecture of Covid-19. Nature [Internet]. 2021 [cited 2021 Dec 06];600(7889):472-477. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674144/pdf/41586_2021_Article_3767.pdf

  35. Almaguer-Mederos L, Cuello-Almarales D, Almaguer-Gotay D. Rol de los genes ACE2 y TMPRSS2 en la susceptibilidad o gravedad de la Covid-19. Anales de la Academia de Ciencias de Cuba [Internet]. 2020 [citado 06 Dic 2021];10(2). Disponible en: Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/799/861

  36. van Blokland IV, Lanting P, Ori APS, Vonk JM, Warmerdam RCA, Herkert JC, et al. Using symptom-based case predictions to identify host genetic factors that contribute to Covid-19 susceptibility. PLoS One [Internet]. 2021 [cited 2021 Dec 06];16(8):[approx.14p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357137/pdf/pone.0255402.pdf

  37. Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, et al. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe Covid-19. Science [Internet]. 2021 [cited 2021 Dec 06];24(4). Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968217/pdf/main.pdf

  38. Medina-Espitia ÓL, Mendoza-Beltrán F, Anaya-Almanza AM, Molano-Salazar ÓA. Covid-19 y metabolismo: una mirada más allá del sistema respiratorio y de la enfermedad trombótica. Rev Colomb Cardiol [Internet]. 2021 [citado 06 Dic 2021];28(4):366-373. Disponible en: Disponible en: http://www.scielo.org.co/pdf/rcca/v28n4/0120-5633-rcca-28-4-366.pdf

  39. Bermúdez-Garcell A, Serrano-Gámez N, Teruel-Ginés R, Sánchez-Sánchez R, Sigcho-Romero C. Mecanismos básicos de la epigenética. CCM [Internet]. 2020 [citado 06 Dic 2021];24(1). Disponible en: Disponible en: http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3448/1516

  40. Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of Covid-19 infection in obese patients. Obes Med [Internet]. 2020 [cited 2021 Dec 17];9:[approx.5p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368415/pdf/main.pdf

  41. Polverino F, Kheradmand F. Covid-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med [Internet]. 2021 [cited 2021 Dec 17];7:[approx.8p.]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847987/pdf/fmed-07-627278.pdf




2020     |     www.medigraphic.com